India Cements has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The Board of Directors approved these results on October 17, 2025. Key figures from the reports show both positive and negative trends, highlighting challenges and strategic decisions impacting the company’s financial health.
Financial Performance Overview
India Cements’ Board has approved the standalone and consolidated financial results for Q2 2026. These results offer insights into the company’s operational and financial status during the period. The reports, which were reviewed by the Audit Committee, are now available on the company website.
Standalone Financial Results Highlights
Total Income reached ₹1,130.55 Crores. However, the company faced a loss before exceptional items and tax of ₹11.30 Crores. After accounting for tax, the loss from continuing operations was ₹6.86 Crores. Earnings per share stood at ₹(0.22). The results reflect an evolving financial landscape with both challenges and strategic adaptations.
Consolidated Financial Results Summary
Consolidated total income amounted to ₹1,146.04 Crores. There was a profit before exceptional items and tax of ₹10.40 Crores. Factoring in the share of profit/loss of associates, the net loss stood at ₹8.81 Crores. The consolidated earnings per share came in at ₹0.28. The mixed figures underline the diverse performance across different segments and investments.
Key Strategic Moves
During the quarter, India Cements continued to streamline its operations. The company issued commercial papers amounting to ₹100 Crores at a discount rate of 5.89%. This financial instrument is due for redemption on November 11, 2025. Additionally, there was an approval to sell the entire equity stake in its subsidiary, Industrial Chemicals & Monomers Ltd (ICML), for a consideration of ₹97.68 crores.
Source: BSE